MET and breast neoplasm: Furthermore, a recent study showed that CIN-induced breast tumours which had relapsed and were now KRAS-independent had recurrent novel subclonal copy number amplifications of another oncogene, MET, which encodes the receptor tyrosine kinase cMET (Salgueiro et al. 2020).